Patents Assigned to Epilobium, Inc.
  • Methods of use for oenothein A and B from species
    Patent number: 11123356
    Abstract: The invention provides medicaments comprising an oenothein, including oral formulations to treat inflammation or to treat hormone balance in perimenopausal, menopausal and postmenopausal women. The oenothein for use in such formulations such as oenothein A or oenothein B maybe purified from natural sources, such as Epilobium.
    Type: Grant
    Filed: March 9, 2018
    Date of Patent: September 21, 2021
    Assignee: Epilobium, Inc.
    Inventor: Robert Jacquet